Browse NSN 6505-01-221-3297 Listing of Levothyroxine Sodiu

It is our pleasure to inform you that part number NDC00378-1800-01, NDC60793-0850-01 listed under NSN 6505-01-221-3297 is now available and ready to ship from Fulfillment By ASAP. This part described as a Levothyroxine Sodiu manufactured by Mylan Pharmaceuticals Inc, Pfizer Inc. If you’d like a quick quote for NSN 6505-01-221-3297, please fill out the form from below. Are you looking to have it delivered today or tomorrow? We can help! Simply complete the Request For Quote (RFQ) form given below to get started, and we will get back to you within 15 minutes!


Alternative NSN: 6505-01-221-3297
Item Name: Levothyroxine Sodiu
Federal Supply Class (FSC): 6505 Drugs and Biologicals
NIIN: 012213297
NCB Code: USA (01)
Manufacturers: Mylan Pharmaceuticals Inc , Pfizer Inc
Part No Manufacturer Item Name QTY RFQ
NDC00378-1800-01 mylan pharmaceuticals inc levothyroxine sodiu Avl RFQ
NDC60793-0850-01 pfizer inc levothyroxine sodiu Avl RFQ

Characteristics Data of NSN 6505012213297

MRCCriteriaCharacteristic
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH0.025 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
CQCTPRIMARY CONTAINER TYPEBOTTLE
CRLKPRIMARY CONTAINER CONTENT QUANTITY100.000 TABLETS
CXCYIII PART NAME ASSIGNED BY CONTROLLING AGENCYLEVOTHYROXINE SODIUM TABLETS USP 0.025MG 100S BT
MDESMEDICAL DESIGNATIONUNITED STATES PHARMACOPEIA

Search More Relevant NSN for 6505-01-221-3297, 6505012213297

Send Instant RFQ

Low Price

Warrantied inventory at competitive prices

Find it fast

Search the world's largest inventory of nsn components by manufacturer, category or part number

Quality guaranteed

We sell only warrantied and traceable parts

Get it fast

All inventory ready to ship from our sellers

Semiconductor's Certifications and Memberships

Thank You for Visiting Fulfillment By ASAP!

Don't Miss! Lowest Quote for your desired part. We stocked over 5 million+ parts. "Get a quick quote!"

Request for Quote

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.